Table 1.
Characteristics of epithelial ovarian cancer patients included in the study at the time of ascites sampling. Staging classification followed FIGO Committee on Gynecologic Oncology guidelines.
| Patient’s Code | Age (Years) | Stage (FIGO) | Histological Classification | Ascites Cytology Results for EOC Cells |
|---|---|---|---|---|
| 21 | 57 | IIB | High-grade serous adenocarcinoma | Negative |
| 24 | 64 | IIIC | Low-grade serous adenocarcinoma | Positive |
| 30 | 63 | IIIC | High-grade serous adenocarcinoma | Negative |
| 40 | 51 | IIIC | High-grade serous adenocarcinoma | Positive |
| 55 | 56 | IIIC | High-grade serous adenocarcinoma | Positive |
| 61 | 58 | IIIC | High-grade serous adenocarcinoma | Negative |
| 70 | 50 | IIIC | Adenocarcinoma NOS | Negative |
| 73 | 71 | IV | High-grade serous adenocarcinoma | Negative |
| 74 | 43 | IIIC | Adenocarcinoma NOS | Positive |
| 75 | 64 | IIIC | High-grade serous adenocarcinoma | Negative |
| 82 | 45 | IIIC | High-grade serous adenocarcinoma | Positive |
| 86 | 70 | IIIC | Adenocarcinoma NOS | Negative |
| 89 | 79 | IV | High-grade serous adenocarcinoma | Positive |
| 93 | 38 | IIIC | Mucinous adenocarcinoma | Negative |
NOS = not otherwise specified.